%0 Journal Article
%T Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer¡¯s disease
%A Bruno Vellas
%A Christine Furtek
%A Christopher Lines
%A Erin Mahoney
%A James Kost
%A Jeffrey L. Cummings
%A Julie Stone
%A Michael F. Egan
%A Paul S. Aisen
%A Pierre N. Tariot
%A Tiffini Voss
%A Yuki Mukai
%J Archive of "Alzheimer's Research & Therapy".
%D 2019
%R 10.1186/s13195-019-0520-1
%K Verubecestat
%K BACE inhibitor
%K Amyloid
%K Alzheimer¡¯s disease
%K Clinical trial
%K Safety
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685277/